Summary

The global Neurosurgery Operating Table market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
An operating table, sometimes called operating room table, is the table on which the patient lies during a surgical operation.[1] This surgical equipment is usually found inside the surgery room of a hospital. Neurosurgical operating table is a kind of operating table, which is specifically used in the neurosurgical.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Neurosurgery Operating Table market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Getinge
Hill-Rom
Skytron
STERIS
Stryker
Mizuho
Alvo
UFSK-OSYS
Medifa-hesse
BiHealthcare
AGA Sanitätsartikel
Lojer
Schmitz u. Söhne
Schaerer Medical
Brumaba
Bender
Merivaara
Infinium Medical
Image Diagnostics
Mindray Medical
PAX Medical
Segment by Type
Motorized
Non-motorized
Segment by Application
Hospital
Clinic
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Neurosurgery Operating Table study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Neurosurgery Operating Table: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Neurosurgery Operating Table Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Motorized
1.2.3 Non-motorized
1.3 Market Segmentation by Application
1.3.1 Global Neurosurgery Operating Table Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Neurosurgery Operating Table Revenue Estimates and Forecasts 2020-2031
2.2 Global Neurosurgery Operating Table Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Neurosurgery Operating Table Sales Estimates and Forecasts 2020-2031
2.4 Global Neurosurgery Operating Table Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Neurosurgery Operating Table Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Neurosurgery Operating Table Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Motorized Market Size by Manufacturers
3.5.2 Non-motorized Market Size by Manufacturers
3.6 Global Neurosurgery Operating Table Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Neurosurgery Operating Table Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Neurosurgery Operating Table Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Neurosurgery Operating Table Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Neurosurgery Operating Table Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Neurosurgery Operating Table Sales and Revenue by Type (2020-2031)
6.4 North America Neurosurgery Operating Table Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Neurosurgery Operating Table Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Neurosurgery Operating Table Sales and Revenue by Type (2020-2031)
7.4 Europe Neurosurgery Operating Table Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Neurosurgery Operating Table Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Neurosurgery Operating Table Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Neurosurgery Operating Table Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Neurosurgery Operating Table Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Neurosurgery Operating Table Sales and Revenue by Type (2020-2031)
9.4 Central and South America Neurosurgery Operating Table Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Neurosurgery Operating Table Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Neurosurgery Operating Table Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Neurosurgery Operating Table Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Neurosurgery Operating Table Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Getinge
11.1.1 Getinge Corporation Information
11.1.2 Getinge Business Overview
11.1.3 Getinge Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.1.4 Getinge Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Getinge Neurosurgery Operating Table Sales by Product in 2024
11.1.6 Getinge Neurosurgery Operating Table Sales by Application in 2024
11.1.7 Getinge Neurosurgery Operating Table Sales by Geographic Area in 2024
11.1.8 Getinge Neurosurgery Operating Table SWOT Analysis
11.1.9 Getinge Recent Developments
11.2 Hill-Rom
11.2.1 Hill-Rom Corporation Information
11.2.2 Hill-Rom Business Overview
11.2.3 Hill-Rom Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.2.4 Hill-Rom Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Hill-Rom Neurosurgery Operating Table Sales by Product in 2024
11.2.6 Hill-Rom Neurosurgery Operating Table Sales by Application in 2024
11.2.7 Hill-Rom Neurosurgery Operating Table Sales by Geographic Area in 2024
11.2.8 Hill-Rom Neurosurgery Operating Table SWOT Analysis
11.2.9 Hill-Rom Recent Developments
11.3 Skytron
11.3.1 Skytron Corporation Information
11.3.2 Skytron Business Overview
11.3.3 Skytron Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.3.4 Skytron Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Skytron Neurosurgery Operating Table Sales by Product in 2024
11.3.6 Skytron Neurosurgery Operating Table Sales by Application in 2024
11.3.7 Skytron Neurosurgery Operating Table Sales by Geographic Area in 2024
11.3.8 Skytron Neurosurgery Operating Table SWOT Analysis
11.3.9 Skytron Recent Developments
11.4 STERIS
11.4.1 STERIS Corporation Information
11.4.2 STERIS Business Overview
11.4.3 STERIS Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.4.4 STERIS Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 STERIS Neurosurgery Operating Table Sales by Product in 2024
11.4.6 STERIS Neurosurgery Operating Table Sales by Application in 2024
11.4.7 STERIS Neurosurgery Operating Table Sales by Geographic Area in 2024
11.4.8 STERIS Neurosurgery Operating Table SWOT Analysis
11.4.9 STERIS Recent Developments
11.5 Stryker
11.5.1 Stryker Corporation Information
11.5.2 Stryker Business Overview
11.5.3 Stryker Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.5.4 Stryker Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Stryker Neurosurgery Operating Table Sales by Product in 2024
11.5.6 Stryker Neurosurgery Operating Table Sales by Application in 2024
11.5.7 Stryker Neurosurgery Operating Table Sales by Geographic Area in 2024
11.5.8 Stryker Neurosurgery Operating Table SWOT Analysis
11.5.9 Stryker Recent Developments
11.6 Mizuho
11.6.1 Mizuho Corporation Information
11.6.2 Mizuho Business Overview
11.6.3 Mizuho Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.6.4 Mizuho Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Mizuho Recent Developments
11.7 Alvo
11.7.1 Alvo Corporation Information
11.7.2 Alvo Business Overview
11.7.3 Alvo Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.7.4 Alvo Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Alvo Recent Developments
11.8 UFSK-OSYS
11.8.1 UFSK-OSYS Corporation Information
11.8.2 UFSK-OSYS Business Overview
11.8.3 UFSK-OSYS Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.8.4 UFSK-OSYS Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 UFSK-OSYS Recent Developments
11.9 Medifa-hesse
11.9.1 Medifa-hesse Corporation Information
11.9.2 Medifa-hesse Business Overview
11.9.3 Medifa-hesse Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.9.4 Medifa-hesse Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Medifa-hesse Recent Developments
11.10 BiHealthcare
11.10.1 BiHealthcare Corporation Information
11.10.2 BiHealthcare Business Overview
11.10.3 BiHealthcare Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.10.4 BiHealthcare Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 BiHealthcare Recent Developments
11.11 AGA Sanitätsartikel
11.11.1 AGA Sanitätsartikel Corporation Information
11.11.2 AGA Sanitätsartikel Business Overview
11.11.3 AGA Sanitätsartikel Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.11.4 AGA Sanitätsartikel Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 AGA Sanitätsartikel Recent Developments
11.12 Lojer
11.12.1 Lojer Corporation Information
11.12.2 Lojer Business Overview
11.12.3 Lojer Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.12.4 Lojer Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Lojer Recent Developments
11.13 Schmitz u. Söhne
11.13.1 Schmitz u. Söhne Corporation Information
11.13.2 Schmitz u. Söhne Business Overview
11.13.3 Schmitz u. Söhne Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.13.4 Schmitz u. Söhne Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Schmitz u. Söhne Recent Developments
11.14 Schaerer Medical
11.14.1 Schaerer Medical Corporation Information
11.14.2 Schaerer Medical Business Overview
11.14.3 Schaerer Medical Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.14.4 Schaerer Medical Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Schaerer Medical Recent Developments
11.15 Brumaba
11.15.1 Brumaba Corporation Information
11.15.2 Brumaba Business Overview
11.15.3 Brumaba Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.15.4 Brumaba Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Brumaba Recent Developments
11.16 Bender
11.16.1 Bender Corporation Information
11.16.2 Bender Business Overview
11.16.3 Bender Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.16.4 Bender Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Bender Recent Developments
11.17 Merivaara
11.17.1 Merivaara Corporation Information
11.17.2 Merivaara Business Overview
11.17.3 Merivaara Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.17.4 Merivaara Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Merivaara Recent Developments
11.18 Infinium Medical
11.18.1 Infinium Medical Corporation Information
11.18.2 Infinium Medical Business Overview
11.18.3 Infinium Medical Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.18.4 Infinium Medical Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Infinium Medical Recent Developments
11.19 Image Diagnostics
11.19.1 Image Diagnostics Corporation Information
11.19.2 Image Diagnostics Business Overview
11.19.3 Image Diagnostics Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.19.4 Image Diagnostics Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Image Diagnostics Recent Developments
11.20 Mindray Medical
11.20.1 Mindray Medical Corporation Information
11.20.2 Mindray Medical Business Overview
11.20.3 Mindray Medical Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.20.4 Mindray Medical Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Mindray Medical Recent Developments
11.21 PAX Medical
11.21.1 PAX Medical Corporation Information
11.21.2 PAX Medical Business Overview
11.21.3 PAX Medical Neurosurgery Operating Table Product Models, Descriptions and Specifications
11.21.4 PAX Medical Neurosurgery Operating Table Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 PAX Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Neurosurgery Operating Table Industry Chain
12.2 Neurosurgery Operating Table Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Neurosurgery Operating Table Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Neurosurgery Operating Table Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Neurosurgery Operating Table Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Neurosurgery Operating Table Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details